Global Cardiac Rhythm Management market to hit $36B by 2032. Leadless pacing and pulsed field ablation lead the industry.

BIOTRONIK today announced the launch of the new Acticor Sky and Rivacor Sky device family featuring the world's first CE-approved left bundle branch area pacing (LBBAP) high-voltage device. These next ...

Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...

In today’s episode, we are joined by Bruce Wilkoff, MD, American Heart Association volunteer expert and Director Cardiac Pacing and Tachyarrhythmia Devices at Cleveland Clinic, to discuss ...

Estimates suggest that around three million Americans are living with cardiac pacemakers, according to the American Heart Association. Now, thanks to MountainStar Healthcare, a new kind of pacemaker – ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

For the past two decades, catheter ablation stole most of the excitement in electrophysiology. Cardiac pacing was seen as necessary but boring. His-bundle pacing earned only modest attention. But at ...

Pacing device implants (PDIs) or implantable cardioverter-defibrillators (ICD) may be placed to treat or prevent the consequences of amyloid deposits (heart failure and conduction disturbances) in ...

It’s possible that consumer “smart” devices that come with bioimpedance technology to provide measurements of body composition can interfere with certain cardiac implantable electronic devices (CIEDs) ...